SB125 modernizes Hawaii’s State Enterprise Zone Program by expanding the kinds of activities that can qualify for enterprise zone benefits and by lengthening the period during which qualified businesses may receive tax incentives. The bill adds or clarifies eligibility for retail sales by local manufacturers when the goods are manufactured and sold in the zone, processing of value-added agricultural products, professional services by health care professionals in health-care-related sectors, advanced manufacturing, and cybersecurity technology. It also adds definitions for “tangible personal property” and “value-added agricultural product,” and expressly excludes medical cannabis dispensary activities from qualifying as an eligible business activity.
The bill also changes the qualification and incentive structure for businesses in enterprise zones. It extends the state business tax credit eligibility period from seven years to nine years, and for certain manufacturers and agricultural processors, extends the credit for an additional three years beyond that. It similarly extends the general excise tax exemption period from seven to nine years, and from ten to twelve years for qualifying manufacturing and agricultural businesses. The bill applies the tax credit extension to taxable years beginning after December 31, 2025, and the general excise tax exemption extension beginning January 1, 2027.
Impact
SB125 amends chapter 209E, Hawaii Revised Statutes, governing the State Enterprise Zone Program. It broadens the statutory definition of “eligible business activity,” revises the criteria for qualified businesses, and increases the duration of state tax credits and general excise tax exemptions available to businesses operating in designated enterprise zones. The bill is intended to support local manufacturing, agriculture, health care services, advanced manufacturing, and cybersecurity development, while preserving the existing exclusion for medical cannabis dispensaries.
Sentiment
The available voting history shows strong support for the bill in committee, with unanimous passage in both the Senate Economic Development and Technology Committee and the Senate Ways and Means Committee, each with amendments. The bill’s findings and description indicate a generally favorable policy view centered on economic development, business retention, and job creation in enterprise zones. No committee transcript is available, so the record does not show detailed debate, but the committee votes suggest broad agreement on the need to update the program.
Contention
The main policy issue appears to be how far to expand enterprise zone eligibility and tax benefits. The bill specifically addresses concerns that the existing program was outdated because manufacturers that sell directly to retail consumers were often excluded, and it adds new sectors such as health care services, advanced manufacturing, and cybersecurity. Potential points of contention include the fiscal cost of extending tax incentives, whether the expanded categories are sufficiently tied to the original revitalization purpose of enterprise zones, and the explicit exclusion of medical cannabis dispensary activities. The amendments also suggest lawmakers were refining the scope and duration of benefits rather than opposing the overall concept.